Pure Global
NCT05558059

Imaging Retinal Vasculature in Infant Eyes

Elucidating Perifoveal Vasculature Development in Infants
Duke University·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Retinopathy of Prematurity
Drug/Device/Intervention
Handheld Optical Coherence Tomography with OCT Angiography
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Duke University
Location
Durham,Philadelphia, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 31, 2022
End date
Aug 31, 2027
Enrollment
16 participants
Primary outcome

Change in vascular density of intermediate and deep vascular plexus at the fovea and perifovea

Summary

Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a
 critical location in the retina determining visual acuity and visual function, and the blood
 vessels around it, are abnormally developed in infants with retinopathy of prematurity.
 However, how these blood vessels form during development of the human fovea remains unclear.
 This research will advance our understanding of the fundamental knowledge of how the blood
 vessels around the fovea form in infants, and how they change in diseased states such as
 preterm birth or retinopathy of prematurity.

ICD-10 classifications
Retinopathy of prematurityOther proliferative retinopathyBackground retinopathy and retinal vascular changesDiabetic retinopathyRetinal disorder, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05558059
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05558059 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Not yet recruiting. The study focuses on Retinopathy of Prematurity. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.